Beneficial effects of propylene and polyethylene glycol and saline in the treatment of perennial rhinitis
Authors:
- 1 March 1982
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 12 (2) , 187-196
Abstract
Summary: Although propylene‐and‐polyethylene‐glycol and saline have been used in clinical studies as placebos, their possible therapeutic role as welling agents in the treatment of perennial rhinitis was investigated. Clinical and laboratory response to these agents was measured in eighteen patients during a 2‐week baseline period and with 4 weeks of active treatment in a double blind randomized study. After 2 and 4 weeks there was a significant improvement compared to baseline in nasal function (PPP< 0.01), and less stuffiness at 4 weeks (P< 0.01). There was a significant correlation between improvement in blockage index and nasal biopsies when both were judged independently of the other. This study has demonstrated that wetting agents offer both subjective and objective improvement in the treatment of perennial rhinitis and merit consideration prior to (or along with) other agents with known systemic side effects.Keywords
This publication has 9 references indexed in Scilit:
- Clinical and nasal biopsy response to treatment of perennial rhinitisJournal of Allergy and Clinical Immunology, 1980
- Clinical Investigation of Allergic Rhinitis and Allied ConditionsAllergy, 1979
- Immunological parameters in perennial rhinitisClinical & Experimental Allergy, 1979
- Double-blind trial comparing flunisolide and placebo for the treatment of perennial rhinitisClinical & Experimental Allergy, 1978
- Treatment of ragweed hay fever with an intranasal spray containing flunisolide, a new synthetic corticosteroidJournal of Allergy and Clinical Immunology, 1976
- INTRA-NASAL BECLOMETHASONE DIPROPIONATE IN VASOMOTOR RHINITISAllergy, 1976
- The Placebo EffectJAMA, 1975
- The placebo effect. A neglected asset in the care of patients1975
- Assessing degree of nasal patency by measuring peak expiratory flow rate through the noseJournal of Allergy and Clinical Immunology, 1973